{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-25-027716","form_type":"8-K","ticker":"CLPT","cik":"0001285550","company_name":"ClearPoint Neuro, Inc.","filed_at":"2025-02-26T23:59:59+00:00","discovered_at":"2026-05-14T18:03:03.186624+00:00","generated_at":"2026-05-26T03:24:22.735965+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"ClearPoint Neuro reports record FY2024 revenue $31.4M, 31% growth; guides FY2025 $36-41M","bullets":["FY 2024 revenue $31.4M (+31% YoY); Q4 revenue $7.8M (+14% YoY).","Gross margin improved to 61% from 57%; operating expenses rose 8% to $38.9M.","Repaid $10M convertible note; cash $20.1M; operational cash burn down 35% to $9.0M.","2025 revenue guidance $36-41M, implying 15-31% growth.","Biologics/drug delivery revenue up 76% to $18.6M; added 25 new centers in 2024."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-25-027716","json":"https://secwatch.observer/filing/0000950170-25-027716.json","markdown":"https://secwatch.observer/filing/0000950170-25-027716.md","text":"https://secwatch.observer/filing/0000950170-25-027716.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1285550/000095017025027716/0000950170-25-027716-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1285550/000095017025027716/clpt-20250226.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-26T03:24:22.735965+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}